Outcome of maintenance systemic chemotherapy with drug-free interval for metastatic urothelial carcinoma

OBJECTIVE: Aiming to achieve long-term disease control, maintenance systemic chemotherapy (MSC) with a 1–3-month drug-free interval is continued in selected patients. We report our experience of MSC for metastatic urothelial carcinoma (UC). METHODS: Of 228 metastatic UC patients treated with systemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, T, Minami, K, Harabayashi, T, Sazawa, A, Chiba, H, Kikuchi, H, Miyata, H, Matsumoto, R, Osawa, T, Maruyama, S, IshizakiIshizaki, J, Mochizuki, T, Chiba, S, Akino, T, Murakumo, M, Miyajima, N, Tsuchiya, K, Murai, S, Shinohara, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886465/
https://www.ncbi.nlm.nih.gov/pubmed/31187865
http://dx.doi.org/10.1093/jjco/hyz084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886465/
https://www.ncbi.nlm.nih.gov/pubmed/31187865
http://dx.doi.org/10.1093/jjco/hyz084

Ejemplares similares